Kindred Biosciences (KIN) – Major News
-
Elanco (ELAN) Announces Agreement to Acquire Kindred Biosciences (KIN) for $9.25 Per Share
-
Kindred Biosciences (KIN) Reports In-Line Q1 EPS, Revenues Miss
-
Kindred Biosciences (KIN) Tops Q4 EPS by 1c
-
Kindred Biosciences (KIN) Misses Q4 EPS by 4c
-
Kindred Biosciences (KIN) Misses Q3 EPS by 2c
-
Kindred Biosciences (KIN) Misses Q1 EPS by 1c
-
Kindred Biosciences (KIN) Misses Q4 EPS by 2c
-
Kindred Biosciences (KIN) Reports In-Line Q2 EPS
-
Kindred Biosciences (KIN) Reports In-Line Q1 EPS
-
Kindred Biosciences (KIN) Announces FDA Approval of Mirataz for Cat Weigh Loss
-
Kindred Biosciences (KIN) Misses Q4 EPS by 4c
-
Kindred Biosciences (KIN) Tops Q3 EPS by 4c
-
Kindred Biosciences (KIN) Tops Q2 EPS by 3c
-
Kindred Biosciences (KIN) Tops Q4 EPS by 7c
-
Kindred Biosciences (KIN) Receives Technical Section Complete Letter for Effectiveness from FDA for Mirataz New Animal Drug Application
-
Kindred Biosciences (KIN) Tops Q3 EPS by 5c
-
Kindred Biosciences (KIN) Tops Q2 EPS by 7c
-
Kindred Biosciences (KIN) Tops Q1 EPS by 1c
-
Kindred Biosciences (KIN) Tops Q4 EPS by 12c
-
Kindred Biosciences (KIN) Announces Top-line KIND-012 Data; Dog Study Missed Primary Endpoint
-
Kindred Biosciences (KIN) Tops Q3 EPS by 8c
-
Kindred Biosciences (KIN) Tops Q2 EPS by 9c
-
Kindred Biosciences (KIN) Tops Q1 EPS by 7c
-
Kindred Biosciences (KIN) Tops Q4 EPS by 9c
-
Kindred Biosciences (KIN) to Discontinue its AtoKin Study
-
Kindred Biosciences (KIN) Reports CereKin KB010 Missed Primary Endpoint
-
Kindred Biosciences (KIN) IPO Opens Sharply Higher
-
Kindred Biosciences (KIN) IPO Prices at $7, Middle of Range
Back to KIN Stock Lookup